《HBV/HCV相关性肝细胞癌抗病毒治疗专家共识》解读

被引：1

作者：

董菁

江家骥

机构：

[1] 福建医科大学附属第一医院肝病中心

来源：

临床肝胆病杂志 | 2014年 / 30卷 / 07期

关键词：

乙型肝炎; 丙型肝炎; 癌,肝细胞; 治疗; 指南;

D O I：

暂无

中图分类号：

R735.7 [肝肿瘤];

学科分类号：

100112 [医学生物化学与分子生物学];

摘要：

<正>HBV和HCV慢性感染是我国肝细胞癌(HCC)主要的病因,病毒持续高水平复制对HCC患者的预后会产生重大影响。HCC是慢性嗜肝病毒感染的延续,又以肝硬化为基础,临床工作中需要多学科共同参与治疗方案的设计和执行。2013年中华医学会肝病学分会主持制订了《HBV/HCV相关性肝细胞癌抗病毒治疗专家建议》[1],在临床推广过程中受到临床一线相关科室广泛欢迎。之后在吴孟超院士和汤钊猷院士指导下,经

引用

页码：592 / 595

页数：4

共 17 条

[1]

A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma [J].

Huang, T. -S. ;

Shyu, Y. -C. ;

Chen, H. -Y. ;

Yuan, S. -S. ;

Shih, J. -N. ;

Chen, P. -J. .

JOURNAL OF VIRAL HEPATITIS, 2013, 20 (10) :729-743

[2]

Early Viral Suppression Predicts Good Postoperative Survivals in Patients with Hepatocellular Carcinoma with a High Baseline HBV-DNA Load [J].

Huang, Gang ;

Yang, Yuan ;

Shen, Feng ;

Pan, Ze-ya ;

Fu, Si-yuan ;

Lau, Wan Yee ;

Zhou, Wei-ping ;

Wu, Meng-chao .

ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (05) :1482-1490

[3]

Posthepatectomy HBV Reactivation in Hepatitis B–Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA Levels.[J].Gang Huang;Eric C. H. Lai;Wan Yee Lau;Wei-ping Zhou;Feng Shen;Ze-ya Pan;Si-yuan Fu;Meng-chao Wu.Annals of Surgery.2013, 3

[4]

Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy [J].

Peng, Jie-Wen ;

Lin, Gui-Nan ;

Xiao, Jian-jun ;

Jiang, Xiao-Mei .

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (04) :356-361

[5]

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update [J].

Liaw, Yun-Fan ;

Kao, Jia-Horng ;

Piratvisuth, Teerha ;

Chan, Henry Lik Yuen ;

Chien, Rong-Nan ;

Liu, Chun-Jen ;

Gane, Ed ;

Locarnini, Stephen ;

Lim, Seng-Gee ;

Han, Kwang-Hyub ;

Amarapurkar, Deepak ;

Cooksley, Graham ;

Jafri, Wasim ;

Mohamed, Rosmawati ;

Hou, Jin-Lin ;

Chuang, Wan-Long ;

Lesmana, Laurentius A. ;

Sollano, Jose D. ;

Suh, Dong-Jin ;

Omata, Masao .

HEPATOLOGY INTERNATIONAL, 2012, 6 (03) :531-561

[6]

Impact of Pegylated Interferon Therapy on Outcomes of Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Hepatic Resection [J].

Tanimoto, Yoshisato ;

Tashiro, Hirotaka ;

Aikata, Hiroshi ;

Amano, Hironobu ;

Oshita, Akihiko ;

Kobayashi, Tsuyoshi ;

Kuroda, Shintaro ;

Tazawa, Hirofumi ;

Takahashi, Shoichi ;

Itamoto, Toshiyuki ;

Chayama, Kazuaki ;

Ohdan, Hideki .

ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (02) :418-425

[7]

Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection [J].

Chen, Li-Tzong ;

Chen, Miin-Fu ;

Li, Lung-An ;

Lee, Po-Huang ;

Jeng, Long-Bin ;

Lin, Deng-Yn ;

Wu, Cheng-Chung ;

Mok, King-Tong ;

Chen, Chao-Long ;

Lee, Wei-Chen ;

Chau, Gar-Yang ;

Chen, Yaw-Sen ;

Lui, Wing-Yui ;

Hsiao, Chin-Fu ;

Whang-Peng, Jacqueline ;

Chen, Pei-Jer .

ANNALS OF SURGERY, 2012, 255 (01) :8-17

[8]

Hepatitis B and C virus hepatocarcinogenesis: Lessons learned and future challenges.[J].Michael J. Bouchard;Sonia Navas-Martin.Cancer Letters.2010, 2

[9]

Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes [J].

Shah, Shimul A. ;

Cleary, Sean P. ;

Wei, Alice C. ;

Yang, Ilun ;

Taylor, Bryce R. ;

Hemming, Alan W. ;

Langer, Bernard ;

Grant, David R. ;

Greig, Paul D. ;

Gallinger, Steven .

SURGERY, 2007, 141 (03) :330-339

[10]

Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma [J].

Jang, JW ;

Choi, JY ;

Bae, SH ;

Kim, CW ;

Yoon, SK ;

Cho, SH ;

Yang, JM ;

Ahn, BM ;

Lee, CD ;

Lee, YS ;

Chung, KW ;

Sun, HS .

JOURNAL OF HEPATOLOGY, 2004, 41 (03) :427-435

← 1 2 →